Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel L. Mason
Observed name:
Rachel L Mason
Institutions:
Georgia Institute of Technology,
Emory University,
Winship Cancer Institute
Observed institutions:
Georgia Institute of Technology,
Emory University,
Winship Cancer Institute
ORCID:
0009-0006-1547-5588
Observed ORCID:
0009-0006-1547-5588
OpenAlex ID:
A5140141320
Engineering serum stable protein nanosheets with reduced macrophage uptake
2026
·
Ishmamul Hoque Sadab
, Raka Chakraborty
, et al.
·
Chemical Communications
·
1
PDF
TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
·
Cancer Research
·
1
356 PolarTIL: a cytokine polarization strategy to improve TIL quantity and quality for adoptive cell therapy
2026
·
Megan M Wyatt
, Rachel L Mason
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
639 Genetic manipulation of 53BP1 phosphorylation enhances T cell cytotoxicity and survival against solid tumors
2026
·
Jessica L Kelliher
, Mousumi Patra
, et al.
·
Journal for ImmunoTherapy of Cancer
Figure S6 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Figure S3 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Table S1 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Figure S5 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Figure S1 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Figure S4 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Data from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Figure S2 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026
·
Ayana T. Ruffin
, Vasili Toliopoulos
, et al.
Show more works
View as search
Works count:
12
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type